Virulence Determinants of Colistin-Resistant K. pneumoniae High-Risk Clones
- PMID: 34068937
- PMCID: PMC8155863
- DOI: 10.3390/biology10050436
Virulence Determinants of Colistin-Resistant K. pneumoniae High-Risk Clones
Abstract
We proposed the hypothesis that high-risk clones of colistin-resistant K. pneumoniae (ColR-Kp) possesses a high number of virulence factors and has enhanced survival capacity against the neutrophil activity. We studied virulence genes of ColR-Kp isolates and neutrophil response in 142 patients with invasive ColR-Kp infections. The ST101 and ST395 ColR-Kp infections had higher 30-day mortality (58%, p = 0.005 and 75%, p = 0.003). The presence of yersiniabactin biosynthesis gene (ybtS) and ferric uptake operon associated gene (kfu) were significantly higher in ST101 (99%, p ≤ 0.001) and ST395 (94%, p < 0.012). Being in ICU (OR: 7.9; CI: 1.43-55.98; p = 0.024), kfu (OR:27.0; CI: 5.67-179.65; p < 0.001) and ST101 (OR: 17.2; CI: 2.45-350.40; p = 0.01) were found to be predictors of 30-day mortality. Even the neutrophil uptake of kfu+-ybtS+ ColR-Kp was significantly higher than kfu--ybtS- ColR-Kp (phagocytosis rate: 78% vs. 65%, p < 0.001), and the kfu+-ybtS+ ColR-Kp survived more than kfu--ybtS- ColR-Kp (median survival index: 7.90 vs. 4.22; p = 0.001). The kfu+-ybtS+ ColR-Kp stimulated excessive NET formation. Iron uptake systems in high-risk clones of colistin-resistant K. pneumoniae enhance the success of survival against the neutrophil phagocytic defense and stimulate excessive NET formation. The drugs targeted to iron uptake systems would be a promising approach for the treatment of colistin-resistant high-risk clones of K. pneumoniae infections.
Keywords: K. pneumoniae; colistin resistance; iron uptake; net formation; phagocytosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8. doi: 10.1016/j.cmi.2015.08.001. Epub 2015 Aug 14. Clin Microbiol Infect. 2015. PMID: 26278669
-
Multiple importations and transmission of colistin-resistant Klebsiella pneumoniae in a hospital in northern India.Infect Control Hosp Epidemiol. 2019 Dec;40(12):1387-1393. doi: 10.1017/ice.2019.252. Epub 2019 Oct 18. Infect Control Hosp Epidemiol. 2019. PMID: 31625832
-
Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection.J Antimicrob Chemother. 2018 May 1;73(5):1235-1241. doi: 10.1093/jac/dkx532. J Antimicrob Chemother. 2018. PMID: 29415120
-
Could Frequent Carbapenem Use Be a Risk Factor for Colistin Resistance?Microb Drug Resist. 2018 Jul/Aug;24(6):774-781. doi: 10.1089/mdr.2016.0321. Epub 2017 Oct 13. Microb Drug Resist. 2018. PMID: 29028174
-
Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital.Acta Microbiol Immunol Hung. 2015 Sep;62(3):233-45. doi: 10.1556/030.62.2015.3.2. Acta Microbiol Immunol Hung. 2015. PMID: 26551567 Review.
Cited by
-
High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.Sci Rep. 2022 Jul 28;12(1):12939. doi: 10.1038/s41598-022-17083-5. Sci Rep. 2022. PMID: 35902639 Free PMC article.
-
The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification.Infect Immun. 2023 Feb 16;91(2):e0001223. doi: 10.1128/iai.00012-23. Epub 2023 Feb 1. Infect Immun. 2023. PMID: 36722977 Free PMC article.
-
Phenotypic and Molecular Characterization of Commensal, Community-Acquired and Nosocomial Klebsiella spp.Microorganisms. 2021 Nov 12;9(11):2344. doi: 10.3390/microorganisms9112344. Microorganisms. 2021. PMID: 34835469 Free PMC article.
-
Long-Read Whole Genome Sequencing Elucidates the Mechanisms of Amikacin Resistance in Multidrug-Resistant Klebsiella pneumoniae Isolates Obtained from COVID-19 Patients.Antibiotics (Basel). 2022 Oct 6;11(10):1364. doi: 10.3390/antibiotics11101364. Antibiotics (Basel). 2022. PMID: 36290022 Free PMC article.
-
The immune responses to different Uropathogens call individual interventions for bladder infection.Front Immunol. 2022 Aug 23;13:953354. doi: 10.3389/fimmu.2022.953354. eCollection 2022. Front Immunol. 2022. PMID: 36081496 Free PMC article. Review.
References
-
- Lee C.R., Lee J.H., Park K.S., Jeon J.H., Kim Y.B., Cha C.J., Jeong B.C., Lee S.H. Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms. Front. Cell Infect. Microbiol. 2017;7:483. doi: 10.3389/fcimb.2017.00483. - DOI - PMC - PubMed
-
- Mammina C., Bonura C., Aleo A., Fasciana T., Brunelli T., Pesavento G., Degl’Innocenti R., Nastasi A. Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy. Int. J. Antimicrob. Agents. 2012;39:543–545. doi: 10.1016/j.ijantimicag.2012.02.012. - DOI - PubMed
LinkOut - more resources
Full Text Sources